Exclusive: MoonLake Immunotherapeutics explores sale-sources

MoonLake Immunotherapeutics , a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale, according to people familiar with the matter.

Related Keywords

Switzerland ,New York ,United States ,David Carnevali ,Moonlake Immunotherapeutics ,Merck Kga ,Abbvie Humira ,Josie Kao ,Abbvie Inc ,Prometheus Biosciences Inc ,Merck Co ,Nasdaq ,Reuters ,Thomson Reuters Trust Principles ,Citigroup ,Eli Lilly ,Dice Therapeutics ,Thomson Reuters Trust ,Rhpi Mergers Acquisitions ,Mtpix ,Erep ,Anlins ,Bact ,Biodrg ,Biz ,Mcfin ,Cmpny ,Deal1 ,Drupro ,Dvst ,Exclsv ,Gen ,Hea ,Heca ,Mrch ,Mrch1 ,Emrg ,News1 ,Phag08 ,Phar ,Phar08 ,Phar1 ,Phmr ,Publ ,Spacs ,Ceeu ,Weu ,Gamers ,Us ,Europ ,Peach ,Ezc ,Namer ,Dude ,Fin ,Topnws ,Topcmb ,